Agencies, 20 August: Wednesday te ekta top ICMR official para parliamentary panel te koise, India para bona Covid-19 vaccine candidates laga phase-two clinical trial toh kothom hobole ase aro vaccine laga emergency authorization toh manibo judi Centre para fesla korile.
Indian Council of Medical Research Director General Balram Bhargava para parliamentary standing committee laga members ke koise, Bharat Biotech, Cadila aro Serum Institute of India para vaccine candidates bona toh trail laga alak alak stages te ase.
Bharat Biotech aro Cadila para melikena Covid-19 vaccine candidates re pase-two trials toh kothom hobole osor te ase.
MP koise, Serum Institute of India para shaa aro Oxford University para bona toh etu hapta phase-2 (b) trials te kushibo. Etu nemide 1,700 patients ke toh desh laga 17 centres te identified ase.
Pandemic logode keman lamba samai nemide manu khan toh thakibole olabo hota te Bhargava koise, final trail toh normally six to nine moina lakae hoilebe government para fesla korile emergency authorization nemide manibo pari.
Add Comment